226 related articles for article (PubMed ID: 33907840)
1. EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cells.
Gao L; Yang T; Zhang S; Liang Y; Shi P; Ren H; Hou P; Chen M
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907840
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
3. Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5.
Zhu Z; Wu Q; Zhang M; Tong J; Zhong B; Yuan K
Oncol Rep; 2021 Feb; 45(2):501-512. PubMed ID: 33416186
[TBL] [Abstract][Full Text] [Related]
4. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer.
Ouyang L; Yang M; Wang X; Fan J; Liu X; Zhang Y; Shu Y
Oncol Rep; 2021 Jan; 45(1):359-367. PubMed ID: 33416121
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways.
Zhou F; Nie L; Feng D; Guo S; Luo R
Oncol Rep; 2017 Sep; 38(3):1857-1866. PubMed ID: 28731178
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
Dong Z; Liu H; Zhao G
Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
[No Abstract] [Full Text] [Related]
8. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA OSER1‑AS1 promotes the malignant properties of non‑small cell lung cancer by sponging microRNA‑433‑3p and thereby increasing Smad2 expression.
Liu X; Huang S; Guan Y; Zhang Q
Oncol Rep; 2020 Aug; 44(2):599-610. PubMed ID: 32627026
[TBL] [Abstract][Full Text] [Related]
10. miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1.
Zhang J; Li J; Li S; Zhou C; Qin Y; Li X
Int J Oncol; 2019 Jun; 54(6):2211-2221. PubMed ID: 30942425
[TBL] [Abstract][Full Text] [Related]
11. TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer.
Zhang T; Liu C; Yu Y; Geng J; Meng Q; Xu S; Zhou F; Chen Y; Jin S; Shen J; Pan B; Meng F; Liu F
Cancer Gene Ther; 2020 Apr; 27(3-4):136-146. PubMed ID: 31243347
[TBL] [Abstract][Full Text] [Related]
12. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
13. MACC‑1 antibody target therapy suppresses growth and migration of non‑small cell lung cancer.
Shi W; Song J; Wang W; Zhang Y; Zheng S
Mol Med Rep; 2017 Nov; 16(5):7329-7336. PubMed ID: 28944826
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
[TBL] [Abstract][Full Text] [Related]
17. Neuropilin 1 modulates TGF‑β1‑induced epithelial‑mesenchymal transition in non‑small cell lung cancer.
Ding Z; Du W; Lei Z; Zhang Y; Zhu J; Zeng Y; Wang S; Zheng Y; Liu Z; Huang JA
Int J Oncol; 2020 Feb; 56(2):531-543. PubMed ID: 31894269
[TBL] [Abstract][Full Text] [Related]
18. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3.
Lv Y; Sui F; Ma J; Ren X; Yang Q; Zhang Y; Guan H; Shi B; Hou P; Ji M
Oncotarget; 2016 Sep; 7(36):57978-57990. PubMed ID: 27517321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]